Bibliographic information
GuidelineWHO recommendations on adolescent health: guidelines approved by the WHO guidelines review committee
Year of Publication2017
Issuing InstitutionWorld Health Organization
Recommendation
New
If preferred regimens are contraindicated or not available, one of the following alternative options is recommended: Abacavir (ABC) + lamivudine (3TC) + efavirenz (EFV) ABC + 3TC + NVP zidovudine (AZT) + 3TC + EFV AZT + 3TC + NVP tenofovir disoproxil fumarate (TDF) + 3TC or emtricitabine (FTC) + nevirapine (NVP)
Recommended in favor
Strong
Certainty of evidence
Moderate